Search Results - "James, Meredith"

VIRTUAL CENTRALIZED PATHOLOGY = MORE ACCURATE PATIENT DATA by James, Meredith

Get full text

Advancing Design Thinking Towards a Better Understanding of Self and Others by James, Meredith

“…In teaching Design Thinking, two key aspects of the discipline continue to emerge: design's move away from materialism; and augmenting better problem-solving…”
Get full text

The life cycle impact for platinum group metals and lithium to 2070 via surplus cost potential by Jasiński, Dominik, Meredith, James, Kirwan, Kerry

“…Purpose A surplus cost potential (SCP) indicator has been developed as a measure of resource scarcity in the life cycle impact assessment (LCIA) context. To…”
Get full text

Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data by Stimpson, Georgia, James, Meredith K., Guglieri, Michela, Wolfe, Amy, Manzur, Adnan, Sarkozy, Anna, Baranello, Giovanni, Muntoni, Francesco, Mayhew, Anna

“…NorthStar Ambulatory Assessment (NSAA) total score (TS) is an ordinal scale to evaluate disease progression and treatment response in ambulatory Duchenne…”
Get full text

Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years by Evans, William J., Hellerstein, Marc, Butterfield, Russell J., Smith, Edward, Guglieri, Michela, Katz, Natalie, Nave, Brittany, Branigan, Lauren, Thera, Stephanie, Vordos, Kalista L., Behar, Laura, Schiava, Marianela, James, Meredith K., Field, Tyler, Mohammed, Hussein, Shankaran, Mahalakshmi

“…Duchenne muscular dystrophy (DMD) results in a progressive loss of functional skeletal muscle mass (MM) and replacement with fibrofatty tissue. Accurate…”
Get full text

Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic by James, Meredith K., Rose, Kristy, Alfano, Lindsay N., Reash, Natalie F., Eagle, Michelle, Lowes, Linda P.

“…Clinical outcome assessments of function or strength, assessed by physical therapists, are commonly used as primary endpoints in clinical trials, natural…”
Get full text

Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids by Schiava, Marianela, Lofra, Robert Muni, Bourke, John P., Díaz‐Manera, Jordi, James, Meredith K., Elseed, Maha A., Malinova, Monika, Michel‐Sodhi, Jassi, Moat, Dionne, Ghimenton, Elisabetta, Mccallum, Michelle, Díaz, Carla Florencia Bolaño, Mayhew, Anna, Wong, Karen, Richardson, Mark, Tasca, Giorgio, Eglon, Gail, Eagle, Michelle, Turner, Cathy, Heslop, Emma, Straub, Volker, Bettolo, Chiara Marini, Guglieri, Michela

“…Background and purpose The transition to adult services, and subsequent glucocorticoid management, is critical in adults with Duchenne muscular dystrophy. This…”
Get full text

Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy by Borland, Holly, Moore, Ursula, Dressman, Heather Gordish, Human, Anri, Mayhew, Anna G., Hilsden, Heather, Rufibach, Laura E., Duong, Tina, Maron, Elke, DeWolf, Brittney, Rose, Kristy, Siener, Catherine, Thiele, Simone, Práxedes, Nieves Sanchez-Aguilera, Canal, Aurélie, Holsten, Scott, Sakamoto, Chikako, Pedrosa-Hernández, Irene, Bello, Luca, Alfano, Lindsay N, Lowes, Linda Pax, James, Meredith K., Straub, Volker

“…•Respiratory impairment is present in up to one-third-of patients with dysferlinopathy.•Spirometry is the gold standard for diagnosis and monitoring of…”
Get full text

Ocean Renewable Energy Storage (ORES) System: Analysis of an Undersea Energy Storage Concept by Slocum, Alexander H., Fennell, Gregory E., Dundar, Gokhan, Hodder, Brian G., Meredith, James D. C., Sager, Monique A.

“…Due to its higher capacity factor and proximity to densely populated areas, offshore wind power with integrated energy storage could satisfy > 20% of U.S…”
Get full text

Water T2 could predict functional decline in patients with dysferlinopathy by Moore, Ursula, Caldas de Almeida Araújo, Ericky, Reyngoudt, Harmen, Gordish‐Dressman, Heather, Smith, Fiona E., Wilson, Ian, James, Meredith, Mayhew, Anna, Rufibach, Laura, Day, John W., Jones, Kristi J., Bharucha‐Goebel, Diana X., Salort‐Campana, Emmanuelle, Pestronk, Alan, Walter, Maggie C., Paradas, Carmen, Stojkovic, Tanya, Mori‐Yoshimura, Madoka, Bravver, Elena, Pegoraro, Elena, Mendell, Jerry R., Bushby, Kate, Blamire, Andrew M., Straub, Volker, Carlier, Pierre G., Diaz‐Manera, Jordi

“…Background Water T2 (T2H2O) mapping is increasingly being used in muscular dystrophies to assess active muscle damage. It has been suggested as a surrogate…”
Get full text

A digital assay for programmed death-ligand 1 (22C3) quantification combined with immune cell recognition algorithms in non-small cell lung cancer by Paces, Will, Ergon, Elliott, Bueche, Elizabeth, Young, G. Dave, Adisetiyo, Vitria, Luengo, Cris, James, Meredith, Caldwell, Charles, Miller, Dannah, Wambaugh, Morgan, Metcalf, Geoffrey, Gianani, Roberto

“…PD-L1 (22C3) checkpoint inhibitor therapy represents a mainstay of modern cancer immunotherapy for non-small cell lung cancer (NSCLC). In vitro diagnostic…”
Get full text

Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy by Schiava, Marianela, Lofra, Robert Muni, Bourke, John P., James, Meredith K., Díaz-Manera, Jordi, Elseed, Maha A., Michel-Sodhi, Jassi, Moat, Dionne, Mccallum, Michelle, Mayhew, Anna, Ghimenton, Elisabetta, Díaz, Carla Florencia Bolaño, Malinova, Monika, Wong, Karen, Richardson, Mark, Tasca, Giorgio, Grover, Emma, Robinson, Emma-Jayne, Tanner, Stephanie, Eglon, Gail, Behar, Laura, Eagle, Michelle, Turner, Catherine, Verdú-Díaz, José, Heslop, Emma, Straub, Volker, Bettolo, Chiara Marini, Guglieri, Michela

“…We investigated the comorbidities, associated factors, and the relationship between anthropometric measures and respiratory function and functional abilities…”
Get full text

Comparison of strength testing modalities in dysferlinopathy by Reash, Natalie F., James, Meredith K., Alfano, Lindsay N., Mayhew, Anna G., Jacobs, Marni, Iammarino, Megan A., Holsten, Scott, Sakamoto, Chikako, Tateishi, Takayuki, Yajima, Hiroyuki, Duong, Tina, Wolf, Brittney, Gee, Richard, Bharucha‐Goebel, Diana X., Bravver, Elena, Mori‐Yoshimura, Madoka, Bushby, Kate, Rufibach, Laura E., Straub, Volker, Lowes, Linda P.

“…Introduction/Aims Dysferlinopathy demonstrates heterogeneity in muscle weakness between patients, which can progress at different rates over time. Changing…”
Get full text

Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease by Moore, Ursula, Gordish, Heather, Diaz-Manera, Jordi, James, Meredith K., Mayhew, Anna G., Guglieri, Michela, Fernandez-Torron, Roberto, Rufibach, Laura E., Feng, Jia, Blamire, Andrew M., Carlier, Pierre G., Spuler, Simone, Day, John W., Jones, Kristi J., Bharucha-Goebel, Diana X., Salort-Campana, Emmanuelle, Pestronk, Alan, Walter, Maggie C., Paradas, Carmen, Stojkovic, Tanya, Mori-Yoshimura, Madoka, Bravver, Elena, Pegoraro, Elena, Lowes, Linda Pax, Mendell, Jerry R., Bushby, Kate, Straub, Volker

“…•Initial diagnosis does not predict subsequent pattern of muscle weakness in dysferlinopathy.•Pattern of weakness is an overlapping continuum that does not…”
Get full text

Cardiac and pulmonary findings in dysferlinopathy: A 3‐year, longitudinal study by Moore, Ursula, Fernandez‐Torron, Roberto, Jacobs, Marni, Gordish‐Dressman, Heather, Diaz‐Manera, Jordi, James, Meredith K., Mayhew, Anna G., Harris, Elizabeth, Guglieri, Michela, Rufibach, Laura E., Feng, Jia, Blamire, Andrew M., Carlier, Pierre G., Spuler, Simone, Day, John W., Jones, Kristi J., Bharucha‐Goebel, Diana X., Salort‐Campana, Emmanuelle, Pestronk, Alan, Walter, Maggie C., Paradas, Carmen, Stojkovic, Tanya, Mori‐Yoshimura, Madoka, Bravver, Elena, Pegoraro, Elena, Lowes, Linda Pax, Mendell, Jerry R., Bushby, Kate, Bourke, John, Straub, Volker

“…Introduction/Aims There is debate about whether and to what extent either respiratory or cardiac dysfunction occurs in patients with dysferlinopathy. This…”
Get full text

266th ENMC International Workshop: Remote delivery of clinical care and validation of remote clinical outcome assessments in neuromuscular disorders: A response to COVID-19 and proactive planning for the future. Hoofddorp, The Netherlands, 1–3 April 2022 by Alfano, Lindsay N., James, Meredith K., Ramdharry, Gita M., Lowes, Linda P., Coats, Julie, Corderí, José, Costello, Annette, Eagle, Michelle, Elseed, Maha, Gaeta, Alessandra, Gordish-Dressman, Heather, Davies, Elin Haf, Human, Anri, Knudsen, Lone, Leffler, Mindy, Levy, Jennifer, Lilien, Charlotte, Mancini, Maria, Mayhew, Anna, McGrattan, Katlyn, Muni-Lofra, Robert, Peck, Allison, Peck, Nathan, Prada, Valeria, Pylarinou, Hara, Rose, Kristy, Werlauff, Ulla

“…•Remote outcomes may reduce travel burden and access to quality care and research.•Remote testing strategies were implemented in response to the…”
Get full text

Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases by Duong, Tina, Krosschell, Kristin J, James, Meredith K, Nelson, Leslie, Alfano, Lindsay N, Eichinger, Katy, Mazzone, Elena, Rose, Kristy, Lowes, Linda P, Mayhew, Anna, Florence, Julaine, King, Wendy, Senesac, Claudia R, Eagle, Michelle

“…Critical components of successful evaluation of clinical outcome assessments (COAs) in multisite clinical trials and clinical practice are standardized…”
Get full text

Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy by Moore, Ursula, Fernández-Simón, Esther, Schiava, Marianela, Cox, Dan, Gordish-Dressman, Heather, James, Meredith K., Mayhew, Anna, Wilson, Ian, Guglieri, Michela, Rufibach, Laura, Blamire, Andrew, Carlier, Pierre G., Mori-Yoshimura, Madoka, Day, John W., Jones, Kristi J., Bharucha-Goebel, Diana X., Salort-Campana, Emmanuelle, Pestronk, Alan, Walter, Maggie C., Paradas, Carmen, Stojkovic, Tanya, Bravver, Elena, Pegoraro, Elena, Mendell, Jerry R., Bushby, Kate, Diaz-Manera, Jordi, Straub, Volker

“…•Myostatin is lower in non-ambulant than ambulant dysferlinopathy patients.•Myostatin concentration can predict loss of ambulation in dysferlinopathy.•Change…”
Get full text

Thermal burns in electroconvulsive therapy by Ho, Ernest Weisheng, Leonard, Eng, Tih-Shih, Lee, Meredith, Gregory James

“…Electroconvulsive therapy (ECT) is effective for mood disorders and schizophrenia. Thermal burns, while rare, are potentially sight and life threatening. The…”
Get full text

Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study by Moore, Ursula R, Jacobs, Marni, Fernandez-Torron, Roberto, Jang, Jiji, James, Meredith K, Mayhew, Anna, Rufibach, Laura, Mittal, Plavi, Eagle, Michelle, Cnaan, Avital, Carlier, Pierre G, Blamire, Andrew, Hilsden, Heather, Lochmüller, Hanns, Grieben, Ulrike, Spuler, Simone, Tesi Rocha, Carolina, Day, John W, Jones, Kristi J, Bharucha-Goebel, Diana X, Salort-Campana, Emmanuelle, Harms, Matthew, Pestronk, Alan, Krause, Sabine, Schreiber-Katz, Olivia, Walter, Maggie C, Paradas, Carmen, Hogrel, Jean-Yves, Stojkovic, Tanya, Takeda, Shin’ichi, Mori-Yoshimura, Madoka, Bravver, Elena, Sparks, Susan, Diaz-Manera, Jordi, Bello, Luca, Semplicini, Claudio, Pegoraro, Elena, Mendell, Jerry R, Bushby, Kate, Straub, Volker

Get full text